Revolution Medicines (RVMD) falls 0.10% on Moderate Volume September 14

Equities Staff  |

Revolution Medicines Inc (NASDAQ: RVMD) shares fell 0.10%, or $0.03 per share, to close Tuesday at $29.55. After opening the day at $29.46, shares of Revolution Medicines fluctuated between $30.82 and $29.30. 353,552 shares traded hands a decrease from their 30 day average of 432,290. Tuesday's activity brought Revolution Medicines’s market cap to $2,174,319,791.

Revolution Medicines is headquartered in Redwood City, California..

About Revolution Medicines Inc

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers. The company possesses sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.

Visit Revolution Medicines Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Revolution Medicines Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Revolution Medicines Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

FAA Urges Airlines To Take Stronger Action With Unruly, Disruptive Passengers
Freshworks Leaps 32% on First Day of Trading After Pricing Above Filing Range
Twitter Settles Class Action for $809.5 Million Over Providing Misleading Information to Investors
DoorDash Adds Alcohol Delivery in 20 US States, DC, Canada, Australia
Bill Gates Raises More Than $1 Billion for Clean Energy Technology
CVS Health To Hire 25,000 in Virtual Career Event Friday September 24
President Biden's New Alliance With Australia and Britain Angers France and European Union
California Governor Newsom Signs Affordable Housing Law



Market Movers

Sponsored Financial Content